Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites

Journal of Virology

Volumn 75, Issue 24, 2001, Pages 12088-12097

  Fournillier, A ^a   Wychowski, C ^a   Boucreux, D ^a   Baumert, T F ^a   Meunier, J C ^a   Jacobs, D ^a   Muguet, S ^a   Depla, E ^a   Inchauspe G ^a  

^a BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; GLYCAN; GLYCOPROTEIN E1; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; EPITOPE MAPPING; FEMALE; GENE CONSTRUCT; GLYCOSYLATION; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STABILITY; VIRUS ENVELOPE; VIRUS MUTATION; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; FEMALE; GLYCOSYLATION; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 0035202613     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.24.12088-12097.2001     Document Type: Article

References (54)

1. Epidemiology of hepatitis C
2. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: Transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol
3. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization
4. Hepatitis C virus structural proteins assemble into virus-like particles in insect cells
5. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
6. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C
7. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
8. Effects of mutations in glycosylation sites and disulfide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins
9. Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response
10. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus
11. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
12. Limited humoral immunity in hepatitis C virus infection
13. Analysis of a successful immune response against hepatitis C virus
14. Hepatitis C virus envelope proteins: Immunogenicity in humans and their role in diagnosis and vaccine development
15. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
16. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans
17. Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein
18. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
19. Immunobiology of hepatitis C virus (HCV) infection: The role of CD4 T cells in HCV infection
20. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C
21. Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells
22. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
23. + T-cell response in acute hepatitis C
24. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
25. Strategies and prospects for vaccination against the hepatitis C viruses
26. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: Comparative studies of antibody and T-helper responses following genetic immunization
27. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
28. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
29. Analysis of successful immune responses in persons infected with hepatitis C virus
30. Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides
31. Therapeutic vaccination of chronically infected chimpanzees with the HCV E1 protein
32. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells
33. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex
34. Characterization of truncated forms of hepatitis C virus glycoproteins
35. Characterisation and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast library
36. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the antiviral cell mediated immune responses
37. New mammalian expression vectors
38. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C
39. Concepts and principles of glycobiology
40. Immunity in hepatitis-C infection
41. Glycobiology
42. A role for carbohydrates in immune evasion in AIDS
43. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
44. Complex processing and protein: Protein interactions in the E2:NS2 region of HCV
45. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures
46. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity
47. Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein
48. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
49. DNA immunization: Effect of secretion of DNA-expressed hemagglutinins on antibody responses
50. Lectins as chaperones in glycoprotein folding
51. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
52. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus
53. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment